Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 03, 2023 Filed Feb 7, 2023 22:45 UTC |
Shaff Eric D.Director · CEO and President
|
GrantRestricted Stock Units · Derivative | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-004206 · doc4.xml · derivative · entry 1 Shaff Eric D. · CIK 0001643734 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. F2 · derivative.expiration_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 22:50 UTC |
Ege David S.See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 95,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0000899243-23-004211 · doc4.xml · derivative · entry 2 Ege David S. · CIK 0001829360 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 95,000 shares Expires 2033-02-02 F3 · derivative.exercise_date: The option will vest as to 25% of the shares on February 3, 2024. The remainder of the shares will vest in 12 equal quarterly installments thereafter. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 22:50 UTC |
Ege David S.See Remarks
|
GrantRestricted Stock Units · Derivative | 47,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-004211 · doc4.xml · derivative · entry 1 Ege David S. · CIK 0001829360 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,500 Underlying: Common Stock · 47,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. F2 · derivative.expiration_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 22:43 UTC |
Young Teresa L.See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 85,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0000899243-23-004200 · doc4.xml · derivative · entry 3 Young Teresa L. · CIK 0001814656 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2033-02-02 F4 · derivative.exercise_date: The option will vest as to 25% of the shares on February 3, 2024. The remainder of the shares will vest in 12 equal quarterly installments thereafter. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 22:43 UTC |
Young Teresa L.See Remarks
|
GrantRestricted Stock Units · Derivative | 85,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-004200 · doc4.xml · derivative · entry 2 Young Teresa L. · CIK 0001814656 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units will vest and settle as to 100% of the restricted stock units on August 3, 2024. F3 · derivative.expiration_date: The restricted stock units will vest and settle as to 100% of the restricted stock units on August 3, 2024. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 22:43 UTC |
Young Teresa L.See Remarks
|
GrantRestricted Stock Units · Derivative | 42,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-004200 · doc4.xml · derivative · entry 1 Young Teresa L. · CIK 0001814656 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,500 Underlying: Common Stock · 42,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. F2 · derivative.expiration_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 22:46 UTC |
Henn Matthew RSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 90,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0000899243-23-004208 · doc4.xml · derivative · entry 2 Henn Matthew R. · CIK 0001767321 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2033-02-02 F3 · derivative.exercise_date: The option will vest as to 25% of the shares on February 3, 2024. The remainder of the shares will vest in 12 equal quarterly installments thereafter. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 22:46 UTC |
Henn Matthew RSee Remarks
|
GrantRestricted Stock Units · Derivative | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-004208 · doc4.xml · derivative · entry 1 Henn Matthew R. · CIK 0001767321 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. F2 · derivative.expiration_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 22:42 UTC |
Cloghessy PaulaSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 95,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0000899243-23-004197 · doc4.xml · derivative · entry 2 Cloghessy Paula · CIK 0001744682 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 95,000 shares Expires 2033-02-02 F3 · derivative.exercise_date: The option will vest as to 25% of the shares on February 3, 2024. The remainder of the shares will vest in 12 equal quarterly installments thereafter. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 22:42 UTC |
Cloghessy PaulaSee Remarks
|
GrantRestricted Stock Units · Derivative | 47,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-004197 · doc4.xml · derivative · entry 1 Cloghessy Paula · CIK 0001744682 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,500 Underlying: Common Stock · 47,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. F2 · derivative.expiration_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 16:35 UTC |
Fraser ClaireDirector
|
GrantStock Option (right to buy) · Derivative | 48,000 | $0.00 Strike: $5.47 | $0.00 |
DisclosureSEC source: 0000899243-23-001007 · doc4.xml · derivative · entry 1 Fraser Claire · CIK 0001382031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires 2033-01-03 F1 · derivative.exercise_date: The option will vest in four equal installments on each anniversary of January 4, 2023 or in full immediately prior to the occurrence of a change in control. Read SEC document |
| October 31, 2022 Filed Oct 31, 2022 23:37 UTC |
Ege David S.See Remarks
|
SaleCommon stock | 5,012 | $7.93 | $39,745.16 |
DisclosureSEC source: 0000899243-22-034598 · doc4.xml · nonDerivative · entry 2 Ege David S. · CIK 0001829360 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,734 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover taxes in connection with the vesting of the restricted stock units. Read SEC document |
| October 27, 2022 Filed Oct 31, 2022 18:05 UTC |
Arkowitz DavidChief Financial Officer
|
GrantCommon stock | 42,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-034577 · doc4.xml · nonDerivative · entry 2 Arkowitz David · CIK 0001296999 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,992 F1 · kind: On November 23, 2021, the reporting person was granted an award of 85,000 restricted stock units, which vest in the form of shares of the Issuer's common stock in two equal installments upon the satisfaction of certain performance criteria. On October 27, 2022, the Issuer's Board of Directors determined that the performance criteria for the first installment were met, resulting in the vesting and settlement of the award as to 42,500 shares. Read SEC document |
| October 27, 2022 Filed Oct 31, 2022 23:37 UTC |
Ege David S.See Remarks
|
GrantCommon stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-034598 · doc4.xml · nonDerivative · entry 1 Ege David S. · CIK 0001829360 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,746 F1 · kind: On May 3, 2021, the reporting person was granted an award of 40,000 restricted stock units, which vest in the form of shares of the Issuer's common stock in two equal installments upon the satisfaction of certain performance criteria. On October 27, 2022, the Issuer's Board of Directors determined that the performance criteria for the first installment were met, resulting in the vesting and settlement of the award as to 20,000 shares. Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 20:46 UTC |
Henn Matthew RSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $10.84 | $0.00 |
DisclosureSEC source: 0000899243-22-030735 · doc4.xml · derivative · entry 1 Henn Matthew R. · CIK 0001767321 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2027-07-18 F1 · balance_after: On June 19, 2017, the Reporting Person was granted an option to purchase 70,000 shares of the Issuer's common stock. Subject to the Reporting Person's continued service to the Issuer through each applicable vesting date, the option vests and becomes exercisable in two equal installments upon the satisfaction of certain performance criteria. On September 8, 2022, the Issuer's Board of Directors determined that the performance criteria for the first installment were met, resulting in vesting of the option as to 35,000 shares. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 23:29 UTC |
DesRosier ThomasChief Legal Officer and EVP
|
GrantCOMMON STOCK | 63,492 | $3.15 | $199,999.80 |
DisclosureSEC source: 0000899243-22-025521 · doc4.xml · nonDerivative · entry 1 DesRosier Thomas · CIK 0001435744 · Chief Legal Officer and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,546 Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 23:22 UTC |
Dere Willard HDirector
|
GrantCOMMON STOCK | 31,746 | $3.15 | $99,999.90 |
DisclosureSEC source: 0000899243-22-025513 · doc4.xml · nonDerivative · entry 1 Dere Willard H · CIK 0001311569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,746 Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 19:23 UTC |
Arkowitz DavidChief Financial Officer
|
GrantCOMMON STOCK | 63,492 | $3.15 | $199,999.80 |
DisclosureSEC source: 0000899243-22-025516 · doc4.xml · nonDerivative · entry 1 Arkowitz David · CIK 0001296999 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,492 Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 19:23 UTC |
Kender Richard NDirector
|
GrantCOMMON STOCK | 63,492 | $3.15 | $199,999.80 |
DisclosureSEC source: 0000899243-22-025515 · doc4.xml · nonDerivative · entry 1 Kender Richard N · CIK 0001381205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,492 Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 23:27 UTC |
Henn Matthew RSee Remarks
|
GrantCOMMON STOCK | 47,619 | $3.15 | $149,999.85 |
DisclosureSEC source: 0000899243-22-025520 · doc4.xml · nonDerivative · entry 1 Henn Matthew R. · CIK 0001767321 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,619 Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 23:25 UTC |
Cloghessy PaulaSee Remarks
|
GrantCOMMON STOCK | 31,746 | $3.15 | $99,999.90 |
DisclosureSEC source: 0000899243-22-025518 · doc4.xml · nonDerivative · entry 1 Cloghessy Paula · CIK 0001744682 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,746 Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 23:22 UTC |
Ege David S.See Remarks
|
GrantCOMMON STOCK | 31,746 | $3.15 | $99,999.90 |
DisclosureSEC source: 0000899243-22-025514 · doc4.xml · nonDerivative · entry 1 Ege David S. · CIK 0001829360 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,746 Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 23:21 UTC |
Shaff Eric D.Director · CEO and President
|
GrantCOMMON STOCK | 63,492 | $3.15 | $199,999.80 |
DisclosureSEC source: 0000899243-22-025509 · doc4.xml · nonDerivative · entry 1 Shaff Eric D. · CIK 0001643734 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,334 Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 23:19 UTC |
Zausner MerylDirector
|
GrantCOMMON STOCK | 31,746 | $3.15 | $99,999.90 |
DisclosureSEC source: 0000899243-22-025506 · doc4.xml · nonDerivative · entry 1 Zausner Meryl · CIK 0001742142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,746 Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 23:19 UTC |
Biondi PaulDirector
|
GrantCOMMON STOCK | 47,619 | $3.15 | $149,999.85 |
DisclosureSEC source: 0000899243-22-025505 · doc4.xml · nonDerivative · entry 1 Biondi Paul · CIK 0001744508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,619 Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 17:00 UTC |
Nutritional Health LTP Fund, L.P.10% owner
Flagship Pioneering, LLC10% owner
Afeyan Noubar10% owner
|
PurchaseCommon Stock | 5,825,495 | $3.15 | $18,350,309.25 |
DisclosureSEC source: 0000899243-22-025721 · doc4.xml · nonDerivative · entry 2 Nutritional Health LTP Fund General Partner LLC · CIK 0001780951 · 10% owner Nutritional Health LTP Fund, L.P. · CIK 0001780956 · 10% owner Flagship Pioneering Inc. · CIK 0001400240 · 10% owner AFEYAN NOUBAR · CIK 0001222012 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Flagship Pioneering Fund VII, L.P. Disclosed balance after: 5,825,495 F1 · kind: On July 5, 2022, Nutritional Health LTP Fund, L.P. ("Nutritional LTP") and Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") acquired 2,912,748 shares and 5,825,495 shares, respectively, of the Issuer's Common Stock in a registered direct offering at a price of $3.15 per share. F3 · ownership.nature: Shares held by Flagship Fund VII. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of Flagship Fund VII GP. Dr. Afeyan is the Chief Executive Officer, sole shareholder and director of Flagship Pioneering. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 17:00 UTC |
Nutritional Health LTP Fund, L.P.10% owner
Flagship Pioneering, LLC10% owner
Afeyan Noubar10% owner
|
PurchaseCommon Stock | 2,912,748 | $3.15 | $9,175,156.20 |
DisclosureSEC source: 0000899243-22-025721 · doc4.xml · nonDerivative · entry 1 Nutritional Health LTP Fund General Partner LLC · CIK 0001780951 · 10% owner Nutritional Health LTP Fund, L.P. · CIK 0001780956 · 10% owner Flagship Pioneering Inc. · CIK 0001400240 · 10% owner AFEYAN NOUBAR · CIK 0001222012 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Nutritional Health LTP Fund, L.P. Disclosed balance after: 5,875,711 F1 · kind: On July 5, 2022, Nutritional Health LTP Fund, L.P. ("Nutritional LTP") and Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") acquired 2,912,748 shares and 5,825,495 shares, respectively, of the Issuer's Common Stock in a registered direct offering at a price of $3.15 per share. F2 · ownership.nature: Shares held by Nutritional LTP. Nutritional Health LTP Fund General Partner LLC ("Nutritional LTP GP") is the general partner of Nutritional LTP. Noubar B. Afeyan, Ph.D. ("Dr. Afeyan") is the sole member and manager of Nutritional LTP GP. Each of the reporting persons except for Nutritional LTP disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:30 UTC |
Berenson StephenDirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0000899243-22-023973 · doc4.xml · derivative · entry 1 Berenson Stephen · CIK 0001760671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-06-21 F1 · derivative.exercise_date: The option vests in full on the earlier of June 22, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 16:35 UTC |
Graves KurtDirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0000899243-22-024008 · doc4.xml · derivative · entry 1 Graves Kurt · CIK 0001406337 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-06-21 F1 · derivative.exercise_date: The option vests in full on the earlier of June 22, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 16:32 UTC |
Graves KurtDirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0000899243-22-023989 · doc4.xml · derivative · entry 1 Graves Kurt · CIK 0001406337 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-06-21 F1 · derivative.exercise_date: The option vests in full on the earlier of June 22, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:30 UTC |
Dere Willard HDirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0000899243-22-023972 · doc4.xml · derivative · entry 1 Dere Willard H · CIK 0001311569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-06-21 F1 · derivative.exercise_date: The option will vest in full on the earlier of June 22, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 16:36 UTC |
Kender Richard NDirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0000899243-22-024013 · doc4.xml · derivative · entry 1 Kender Richard N · CIK 0001381205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-06-21 F1 · derivative.exercise_date: The option vests in full on the earlier of June 22, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 16:32 UTC |
Kender Richard NDirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0000899243-22-023990 · doc4.xml · derivative · entry 1 Kender Richard N · CIK 0001381205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-06-21 F1 · derivative.exercise_date: The option vests in full on the earlier of June 22, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:31 UTC |
Ausiello Dennis ADirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0000899243-22-023974 · doc4.xml · derivative · entry 1 Ausiello Dennis A · CIK 0001381994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-06-21 F1 · derivative.exercise_date: The option vests in full on the earlier of June 22, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:35 UTC |
Zausner MerylDirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0000899243-22-024010 · doc4.xml · derivative · entry 1 Zausner Meryl · CIK 0001742142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-06-21 F1 · derivative.exercise_date: The option will vest in full on the earlier of June 22, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:35 UTC |
Biondi PaulDirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0000899243-22-024004 · doc4.xml · derivative · entry 1 Biondi Paul · CIK 0001744508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-06-21 F1 · derivative.exercise_date: The option vests in full on the earlier of June 22, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:32 UTC |
Zausner MerylDirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0000899243-22-023992 · doc4.xml · derivative · entry 1 Zausner Meryl · CIK 0001742142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-06-21 F1 · derivative.exercise_date: The option will vest in full on the earlier of June 22, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:31 UTC |
Behar GregoryDirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0000899243-22-023979 · doc4.xml · derivative · entry 1 Behar Gregory · CIK 0001643766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-06-21 F1 · derivative.exercise_date: The option vests in full on the earlier of June 22, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders. Read SEC document |
| June 15, 2022 Filed Oct 31, 2022 18:05 UTC |
Arkowitz DavidChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-034577 · doc4.xml · derivative · entry 3 Arkowitz David · CIK 0001296999 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: On June 1, 2021, the reporting person was granted an award of restricted stock units, 100% of which vested and settled on June 15, 2022. F3 · derivative.expiration_date: On June 1, 2021, the reporting person was granted an award of restricted stock units, 100% of which vested and settled on June 15, 2022. Read SEC document |
| June 15, 2022 Filed Oct 31, 2022 18:05 UTC |
Arkowitz DavidChief Financial Officer
|
Exercise / conversionCommon stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-034577 · doc4.xml · nonDerivative · entry 1 Arkowitz David · CIK 0001296999 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 02:35 UTC |
Cloghessy PaulaSee Remarks
|
GrantStock Options (right to buy) · Derivative | 190,000 | $0.00 Strike: $7.60 | $0.00 |
DisclosureSEC source: 0000899243-22-005322 · doc4.xml · derivative · entry 1 Cloghessy Paula · CIK 0001744682 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,000 Underlying: Common Stock · 190,000 shares Expires 2032-02-06 F1 · derivative.exercise_date: This option will vest and become exercisable as to 25% of the shares on February 7, 2023. The remainder of the shares will vest and become exercisable in 12 equal quarterly installments thereafter. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:30 UTC |
von Moltke LisaSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $7.38 | $0.00 |
DisclosureSEC source: 0000899243-22-005317 · doc4.xml · derivative · entry 1 von Moltke Lisa · CIK 0001808592 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2032-02-03 F1 · derivative.exercise_date: The option will vest as to 25% of the shares on February 4, 2023. The remainder of the shares will vest in 12 equal quarterly installments thereafter. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:30 UTC |
DesRosier ThomasChief Legal Officer and EVP
|
GrantStock Option (Right to Buy) · Derivative | 130,000 | $0.00 Strike: $7.38 | $0.00 |
DisclosureSEC source: 0000899243-22-005314 · doc4.xml · derivative · entry 1 DesRosier Thomas · CIK 0001435744 · Chief Legal Officer and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2032-02-03 F1 · derivative.exercise_date: The option will vest as to 25% of the shares on February 4, 2023. The remainder of the shares will vest in 12 equal quarterly installments thereafter. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 21:30 UTC |
Arkowitz DavidSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 190,000 | $0.00 Strike: $7.38 | $0.00 |
DisclosureSEC source: 0000899243-22-005316 · doc4.xml · derivative · entry 1 Arkowitz David · CIK 0001296999 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,000 Underlying: Common Stock · 190,000 shares Expires 2032-02-03 F1 · derivative.exercise_date: The option will vest as to 25% of the shares on February 4, 2023. The remainder of the shares will vest in 12 equal quarterly installments thereafter. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:30 UTC |
Ege David S.See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $7.38 | $0.00 |
DisclosureSEC source: 0000899243-22-005320 · doc4.xml · derivative · entry 1 Ege David S. · CIK 0001829360 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2032-02-03 F1 · derivative.exercise_date: The option will vest as to 25% of the shares on February 4, 2023. The remainder of the shares will vest in 12 equal quarterly installments thereafter. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:30 UTC |
Shaff Eric D.Director · President, CEO
|
GrantStock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $7.38 | $0.00 |
DisclosureSEC source: 0000899243-22-005315 · doc4.xml · derivative · entry 1 Shaff Eric D. · CIK 0001643734 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2032-02-03 F1 · derivative.exercise_date: The option will vest as to 25% of the shares on February 4, 2023. The remainder of the shares will vest in 12 equal quarterly installments thereafter. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:30 UTC |
Young Teresa L.See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $7.38 | $0.00 |
DisclosureSEC source: 0000899243-22-005319 · doc4.xml · derivative · entry 1 Young Teresa L. · CIK 0001814656 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2032-02-03 F1 · derivative.exercise_date: The option will vest as to 25% of the shares on February 4, 2023. The remainder of the shares will vest in 12 equal quarterly installments thereafter. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:30 UTC |
Henn Matthew RSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $7.38 | $0.00 |
DisclosureSEC source: 0000899243-22-005313 · doc4.xml · derivative · entry 1 Henn Matthew R. · CIK 0001767321 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2032-02-03 F1 · derivative.exercise_date: The option will vest as to 25% of the shares on February 4, 2023. The remainder of the shares will vest in 12 equal quarterly installments thereafter. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:30 UTC |
Berenson StephenDirector
|
GrantStock Option (right to buy) · Derivative | 23,000 | $0.00 Strike: $19.74 | $0.00 |
DisclosureSEC source: 0000899243-21-024998 · doc4.xml · derivative · entry 1 Berenson Stephen · CIK 0001760671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2031-06-15 F1 · derivative.exercise_date: The option vests in full on the earlier of June 16, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 16:30 UTC |
Graves KurtDirector
|
GrantStock Option (right to buy) · Derivative | 23,000 | $0.00 Strike: $19.74 | $0.00 |
DisclosureSEC source: 0000899243-21-024995 · doc4.xml · derivative · entry 1 Graves Kurt · CIK 0001406337 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2031-06-15 F1 · derivative.exercise_date: The option vests in full on the earlier of June 16, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.